Effect of ligustrazine on hematopoiesis in bone marrow transplantation mice

Sun Hanying , Fang Minghao , Ren Tianhua , Dai Qilin , Liu Wenli , Lu Wu , Xu Huizhen

Current Medical Science ›› 2001, Vol. 21 ›› Issue (8) : 289 -291.

PDF
Current Medical Science ›› 2001, Vol. 21 ›› Issue (8) : 289 -291. DOI: 10.1007/BF02886559
Article

Effect of ligustrazine on hematopoiesis in bone marrow transplantation mice

Author information +
History +
PDF

Abstract

The effect of Ligustrazine on the hematopoiesis after bone marrow transplantation (BMT) in allogenic BMT mice was investigated. After the typical mice model of allogenic BMT had been established, the mice were randomly divided into three groups: BMT group, Ligustrazine group and normal group. The BMT group was given normal saline (0. 2 ml, twice a day) through gastric tube, while the Ligustrazine group was given Ligustrazine through gastric tube (0. 2 ml, twice a day). At the 1st, 7th and 14th day after BMT, we observed the peripheral blood cells and bone marrow nuclear cells (BMNC), as well as the expression level of Heparan Sulfate (HS) and stromal cell derived factor-1 (SDF-1) on bone marrow sections by using immunohistochemistry (SABC-AP), the expression of CXCR4 on the BMNC. The results showed that on the 7th and 14th day, the peripheral blood white cells, platelets, BMNC and the expression levels of CXCR4, HS and SDF-1 were significantly higher in Ligustrazine group than in the BMT group (P<0. 05). It was concluded that Ligustrazine could promote hematopoiesis at the early stage of hematopoietic reconstitution after BMT.

Keywords

Ligustrazine / hematopoiesis / bone marrow / transplantation

Cite this article

Download citation ▾
Sun Hanying, Fang Minghao, Ren Tianhua, Dai Qilin, Liu Wenli, Lu Wu, Xu Huizhen. Effect of ligustrazine on hematopoiesis in bone marrow transplantation mice. Current Medical Science, 2001, 21(8): 289-291 DOI:10.1007/BF02886559

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1995,16:81

[2]

1998,19:178

[3]

MohleR, BantzF, Rafii, et al. . The chemokine receptor CXCR4 is expressed on CD34+ hematopoitetic progenitors and leukemic cell and mediates transendothelial migration induced by stromal cell derived factor-1. Blood, 1997, 914523-4523

[4]

1999,7:138

[5]

GuptaP, OegemaT R, BraizilJ J, et al. . Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood, 1998, 924641-4641

[6]

HanZ C, BellucciS, ShenZ X, et al. . Glycosaminoglycans enhance megakaryo cytopoiesis by modifying the activities of hematopoitic growth regulators. J Cell Physiol, 1996, 16897-97

[7]

BorghesiL A, YamashitaY, KincadeP W. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood, 1999, 93140-140

AI Summary AI Mindmap
PDF

91

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/